Pepose Jay 4
4 · Ocuphire Pharma, Inc. · Filed Apr 15, 2024
Insider Transaction Report
Form 4
Pepose Jay
Director
Transactions
- Award
Common Stock
2024-04-11+32,000→ 139,315 total - Award
Stock Option (right to buy)
2024-04-11+48,000→ 48,000 totalExercise: $1.79Exp: 2034-04-10→ Common Stock (48,000 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest on the one-year anniversary of the grant date of April 11, 2024, subject to the Reporting Person's continuing service.
- [F2]The option will vest in 12 equal monthly installments beginning on May 11, 2024, subject to the Reporting Person's continuing service.